Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/13/24 Pfizer (PFE) Fordadistrogene Movaparvovec for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
6/12/24 UCB (UCB) Bimzelx for Axial Spondyloarthritis Subscribers Only Subscribers Only Subscribers Only
6/10/24 Oculis (OCS) OCS-02 for Dry Eye (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
6/10/24 Moderna (MRNA) mRNA-1083 for Seasonal Influenza Vaccines Subscribers Only Subscribers Only Subscribers Only
6/10/24 Eli Lilly (LLY) Donanemab for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/18/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
05/03/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
05/15/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion